LIFECORE BIOMEDICAL, INC. Capitalized Computer Software, Amortization
LIFECORE BIOMEDICAL, INC. (LFCR) reported Capitalized Computer Software, Amortization of $500.00 thousand for the 12-month period ending 2024-05-26, per its 10-K filed 2024-08-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CapitalizedComputerSoftwareAmortization1 · last filed 2024-08-26
- LIFECORE BIOMEDICAL, INC. capitalized computer software, amortization for fiscal 2024 was $500.00K, a 0.00% change from fiscal 2023.
- LIFECORE BIOMEDICAL, INC. capitalized computer software, amortization for fiscal 2023 was $500.00K, a 25.00% increase from fiscal 2022.
- LIFECORE BIOMEDICAL, INC. capitalized computer software, amortization for fiscal 2022 was $400.00K, a 0.00% change from fiscal 2021.
- LIFECORE BIOMEDICAL, INC. capitalized computer software, amortization for fiscal 2021 was $400.00K, a 33.33% increase from fiscal 2020.
| Period end | Capitalized Computer Software, Amortization 12 month | Capitalized Computer Software, Amortization 12 month as first filed |
|---|---|---|
| 2024-05-26 | $500.00K 10-K · filed 2024-08-26 | |
| 2023-05-28 | $500.00K 10-K · filed 2024-08-26 | |
| 2022-05-29 | $400.00K 10-K · filed 2024-08-26 | $500.00K 10-K · filed 2022-09-14 |
| 2021-05-30 | $400.00K 10-K · filed 2024-03-20 | $1.10M 10-K · filed 2021-07-29 |
| 2020-05-31 | $300.00K 10-K/A · filed 2023-03-16 | $800.00K 10-K · filed 2020-08-14 |
| 2019-05-26 | $900.00K 10-K · filed 2021-07-29 | |
| 2018-05-27 | $600.00K 10-K · filed 2020-08-14 | $632.00K 10-K · filed 2018-08-09 |
| 2017-05-28 | $400.00K 10-K · filed 2019-08-01 | $414.00K 10-K · filed 2017-08-11 |
| 2016-05-29 | $269.00K 10-K · filed 2018-08-09 | |
| 2015-05-31 | $158.00K 10-K/A · filed 2018-03-15 | |
| 2014-05-25 | $189.00K 10-K · filed 2016-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |